CSI Market
Sign In | Register

Atrium Therapeutics Inc (RNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RNA Annual Balance Sheets →
The balance sheet data below highlights changes in Atrium Therapeutics Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent72.33
Marketable Securities, Current SH191.80
Cash & Short-term Investments263.00
Other Current Assets6.41
Prepaid Expense, Current AS4.51
Total Current Assets275.05
Equipment/Property/Plant Net4.07
Other Assets, Noncurrent1.40
Collaboration Receivables Current15.00
Restricted Cash Noncurrent0.42
Operating Lease Right Of Use Asset-
Total Assets280.51
Liabilities
Accounts Payable, Current AC3.51
Accrued Liabilities, Current AC13.31
Other Liabilities, Current14.68
Deferred Compensation Liability, Current LI0.00
Total Current Liabilities31.51
Total Long-term Debt0.00
Other liabilities, Noncurrent34.43
Accrued Compensation And Other Current Liabilities2.09
Operating Lease Liability Current2.68
Contract With Customer Liability Current9.34
Contract With Customer Liability Noncurrent36.35
Contract With Customer Liability Noncurrent-
Total Liabilities65.94
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock222.85
Retained Earnings / Accumulated Deficit-8.06
Accumulated Other Comprehensive Income-0.24
Other Equity-0.24
Common Stockholder's Equity214.58
Total Stockholder's Equity214.58
Liabilities & Stockholder's Equity280.51
4 historic quarters locked

Sign in to unlock the full Atrium Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Atrium Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: rna-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-349488

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.